Search results
Results from the WOW.Com Content Network
William Bradley Coley (January 12, 1862 – April 16, 1936) was an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection as a way to fight cancer, a practice used as far back as 1550 BC. [1]
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
1893 – Use of live bacteria and bacterial lysates to treat tumors – "Coley's Toxins", based on Busch and Fehleisen experiences (William B. Coley) 1894 – Bacteriolysis (Richard Pfeiffer) 1896 – An antibacterial, heat-labile serum component is described (Jules Bordet) 1900 – Antibody formation theory (Paul Ehrlich)
Here are nine of some of the most significant archaeological discoveries in history that changed what humans know about our origins and culture through time. Pompeii and Herculaneum gave a glimpse ...
William B. Coley Award. The William B. Coley Award is given annually to one or more scientists for outstanding achievements in the field of basic immunology and cancer immunology. Awardees receive an honorary medal and $5,000 prize. It is named for the pioneer of cancer immunotherapy, William B. Coley. Lloyd J. Old Award
Coley's toxins (also called Coley's toxin, [1] Coley's vaccine, [2] Coley vaccine, Coley's fluid or mixed bacterial vaccine) is a mixture containing toxins filtered from killed bacteria of species Streptococcus pyogenes and Serratia marcescens, named after William Coley, a surgical oncologist at the Hospital for Special Surgery who developed the mixture in the late 19th century as a treatment ...
The William B. Coley Award for Distinguished Research in Basic and Tumor Immunology is presented annually by the Cancer Research Institute, to scientists [1] who have made outstanding achievements in the fields of basic and tumor immunology and whose work has deepened our understanding of the immune system's response to disease, including cancer.
Also, Parke-Davis distributed Coley's toxins, the first cancer vaccine, which was developed by William Coley to treat osteosarcoma. Additionally, the company entered into a distribution agreement with the Inoculation Department of St Mary's (London) and distributed a number of vaccines for infectious diseases and even acne and cancer.